Actively Recruiting
External Facilitation to Increase Prescribing of Medications for Alcohol Use Disorder in Psychiatric Clinics
Led by University of Maryland, Baltimore · Updated on 2026-06-03
40
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating an implementation facilitation intervention designed to increase the prescribing of medications for alcohol use disorder (MAUD) among patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics. This project aims to improve how these medications are prescribed by supporting clinic staff and educating patients, guided by a health services framework. The intervention includes an external facilitator working with internal clinic champions to provide education about MAUD, training on using standardized screening measures, documentation in electronic health records, and weekly audit and feedback for prescribing practices. The facilitators also support weekly care coordination and provide educational materials for patients. Clinics receive expert consultation and the project spans pre-implementation, implementation, and a post-implementation sustainment phase where clinics continue independently. Participants will be involved through their clinics where staff receive training and education, and patients are informed about MAUD options. Researchers will monitor prescribing rates of these medications six months after the implementation phase ends. Formative evaluation activities will occur throughout the project to assess progress and outcomes over time, supporting sustained changes in clinical practice.
CONDITIONS
Brief Title
External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting
Who Can Participate
Eligibility Criteria
You may qualify if you...
- For prescribers: working as a prescriber, non-prescribing clinician, or administrator at one of the three participating clinics
- For patients: has major mental illness including major depressive disorder, bipolar disorder, schizophrenia spectrum disorders, other psychotic disorders, or posttraumatic stress disorder
- For patients: has alcohol use disorder and is being treated in one of the three participating clinics
You will not qualify if you...
- Age less than 18 years old
- Unable to complete informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration of the implementation facilitation phase
Participants engage in implementation facilitation including education, training, audit and feedback, and care coordination to increase prescribing of medications for alcohol use disorder in psychiatric clinics.
Regular interactions with clinic staff and internal champions during implementation activities
Duration - Post-implementation sustainment period until outcome assessment
Following the implementation facilitation, clinics continue to sustain the changes independently with ongoing access to consultation.
Ongoing monitoring with no scheduled visits
Trial Site Locations
Total: 1 location
1
University of Maryland Baltimore
Baltimore, Maryland, United States, 21201
Actively Recruiting
Research Team
M
Melanie Bennett, PhD
B
Brian Brandler
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here